legislationactive4 updates
HB 3799: Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration.
Tracking HB 3799 through the Oregon Legislature.
Updates
Newest first · click to expandBill ActionJune 27, 2025HB 3799
House: In committee upon adjournment.
TestimonyMarch 27, 2025HB 3799
House: Public Hearing held.
Bill ActionMarch 4, 2025HB 3799
House: Referred to Behavioral Health and Health Care.
Bill ActionFebruary 27, 2025HB 3799